IM Cannabis Corp. (NASDAQ:IMCC) Stock Short Interest Report for September

IM Cannabis Corp. (NASDAQ:IMCC) was the target of a large increase in short interest during the month of September. As of September 30th, there was short interest totaling 74,661 shares, an increase of 64.4% from the September 15th total of 45,409 shares. Based on an average daily volume of 14,912,101 shares, the short-interest ratio is presently 0.0 days. Currently, 38.3% of the company’s stock are short sold.

IM Cannabis Stock Down 1.5%

Shares of IMCC opened at $1.33 on Friday. IM Cannabis has a 52-week low of $1.20 and a 52-week high of $77.10. The business has a fifty day moving average of $2.65 and a 200 day moving average of $5.49. The company has a market cap of $1.32 million, a PE ratio of -0.02 and a beta of 2.21.

IM Cannabis (NASDAQ:IMCC) last issued its earnings results on Thursday, August 13th. The company reported ($0.34) EPS for the quarter. The firm had revenue of $5.34 million for the quarter.

Analysts Set New Price Targets

Several brokerages have issued reports on IMCC. Weiss Ratings reissued a “sell (e+)” rating on shares of IM Cannabis in a research report on Tuesday, July 21st. Wall Street Zen lowered IM Cannabis to a “strong sell” rating in a research note on Saturday, October 10th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, IM Cannabis presently has an average rating of “Sell”.

IM Cannabis Company Profile

IM Cannabis Corp. is a medical cannabis company focused on the cultivation, importation, distribution and sale of cannabis products. The company markets products under the IMC brand and serves patients through regulated medical cannabis channels.

IM Cannabis operates primarily in Israel and Germany. In Israel, the company’s activities include supplying medical cannabis products through pharmacies and other authorized distribution channels. In Germany, it participates in the medical cannabis market through the importation and distribution of pharmaceutical-grade products.

The company was established in 2018 and has developed its business through subsidiaries and strategic partnerships in its target markets.